INS and type 1 diabetes mellitus: Although the small number of mice tested with each pMHCII-NP type precludes definitive determination of any significant differences in therapeutic activity among the three different insulin epitope-based pMHCII-NP types, the outcome of these studies is similar to that reported for three other T1D-relevant pMHCII-NP types (2).